2023
DOI: 10.51387/23-nejsds25
|View full text |Cite
|
Sign up to set email alerts
|

Seamless Clinical Trials with Doubly Adaptive Biased Coin Designs

Abstract: In addition to scientific questions, clinical trialists often explore or require other design features, such as increasing the power while controlling the type I error rate, minimizing unnecessary exposure to inferior treatments, and comparing multiple treatments in one clinical trial. We propose implementing adaptive seamless design (ASD) with response adaptive randomization (RAR) to satisfy various clinical trials’ design objectives. However, the combination of ASD and RAR poses a challenge in controlling th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 71 publications
0
1
0
Order By: Relevance
“…Clinical trialists often grapple with the need to balance statistical power, ethical considerations, and control over the type I error rate. Zhu et al [11] propose an adaptive seamless design (ASD) in conjunction with response adaptive randomization (RAR) to address these challenges. This innovative approach demonstrates how it is possible to achieve efficient and ethical objectives while maintaining control over the type I error rate, a crucial aspect in clinical trials.…”
Section: Research Articlesmentioning
confidence: 99%
“…Clinical trialists often grapple with the need to balance statistical power, ethical considerations, and control over the type I error rate. Zhu et al [11] propose an adaptive seamless design (ASD) in conjunction with response adaptive randomization (RAR) to address these challenges. This innovative approach demonstrates how it is possible to achieve efficient and ethical objectives while maintaining control over the type I error rate, a crucial aspect in clinical trials.…”
Section: Research Articlesmentioning
confidence: 99%